Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Welcker

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Rheumatology International|October 10, 2022
Diagnostic delay stages and pre-diagnostic treatment in patients with suspected rheumatic diseases before special care consultation: results of a multicenter-based studyFranziska Fuchs, Harriet Morf, Jacob Mohn, et al.
Rheumatology International|November 28, 2022
Impairment in cognitive function in patients with axial spondyloarthritis and psoriatic arthritisStefan Kleinert, Florian Schuch, Praxedis Rapp, et al.
Zeitschrift Fur Rheumatologie|September 23, 2025
[Renewed increase in new Janus kinase inhibitor prescriptions : Analysis of the German RHADAR registry]Patrick-Pascal Strunz, Linus Maximilian Risser, Matthias Englbrecht, et al.
Frontiers in Immunology|September 6, 2024
Use of Janus kinase inhibitors before and after European Medicines Agency safety recommendations: a retrospective studyPatrick-Pascal Strunz, Linus Maximilian Risser, Matthias Englbrecht, et al.
Journal of Medical Internet Research|May 20, 2021
A Real-World Rheumatology Registry and Research Consortium: The German RheumaDatenRhePort (RHADAR) RegistryStefan Kleinert, Peter Bartz-Bazzanella, Cay von der Decken, et al.
BMC Health Services Research|October 29, 2022
Digitally-supported patient-centered asynchronous outpatient follow-up in rheumatoid arthritis - an explorative qualitative studyRamona Stenzel, Katharina Hadaschik, Susann May, et al.
Frontiers in Immunology|June 7, 2024
Drug survival superiority of tumor necrosis factor inhibitors and interleukin-17 inhibitors over Janus kinase inhibitors and interleukin-12/23 inhibitors in German psoriatic arthritis outpatients: retrospective analysis of the RHADAR databasePatrick-Pascal Strunz, Matthias Englbrecht, Linus Maximilian Risser, et al.
Rheumatology International|August 13, 2024
Analysis of the shorter drug survival times for Janus kinase inhibitors and interleukin-17 inhibitors compared with tumor necrosis factor inhibitors in a real-world cohort of axial spondyloarthritis patients - a retrospective analysis from the RHADAR networkPatrick-Pascal Strunz, Matthias Englbrecht, Linus Maximilian Risser, et al.
Frontiers in Public Health|March 11, 2022
Patient's Perception of Digital Symptom Assessment Technologies in Rheumatology: Results From a Multicentre StudyJohannes Knitza, Felix Muehlensiepen, Yuriy Ignatyev, et al.
Journal of Medical Internet Research|July 23, 2024
Diagnostic Accuracy of a Mobile AI-Based Symptom Checker and a Web-Based Self-Referral Tool in Rheumatology: Multicenter Randomized Controlled TrialJohannes Knitza, Koray Tascilar, Franziska Fuchs, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Rheumatology International|October 10, 2022
Diagnostic delay stages and pre-diagnostic treatment in patients with suspected rheumatic diseases before special care consultation: results of a multicenter-based studyFranziska Fuchs, Harriet Morf, Jacob Mohn, et al.
Rheumatology International|November 28, 2022
Impairment in cognitive function in patients with axial spondyloarthritis and psoriatic arthritisStefan Kleinert, Florian Schuch, Praxedis Rapp, et al.
Zeitschrift Fur Rheumatologie|September 23, 2025
[Renewed increase in new Janus kinase inhibitor prescriptions : Analysis of the German RHADAR registry]Patrick-Pascal Strunz, Linus Maximilian Risser, Matthias Englbrecht, et al.
Frontiers in Immunology|September 6, 2024
Use of Janus kinase inhibitors before and after European Medicines Agency safety recommendations: a retrospective studyPatrick-Pascal Strunz, Linus Maximilian Risser, Matthias Englbrecht, et al.
Journal of Medical Internet Research|May 20, 2021
A Real-World Rheumatology Registry and Research Consortium: The German RheumaDatenRhePort (RHADAR) RegistryStefan Kleinert, Peter Bartz-Bazzanella, Cay von der Decken, et al.
BMC Health Services Research|October 29, 2022
Digitally-supported patient-centered asynchronous outpatient follow-up in rheumatoid arthritis - an explorative qualitative studyRamona Stenzel, Katharina Hadaschik, Susann May, et al.
Frontiers in Immunology|June 7, 2024
Drug survival superiority of tumor necrosis factor inhibitors and interleukin-17 inhibitors over Janus kinase inhibitors and interleukin-12/23 inhibitors in German psoriatic arthritis outpatients: retrospective analysis of the RHADAR databasePatrick-Pascal Strunz, Matthias Englbrecht, Linus Maximilian Risser, et al.
Rheumatology International|August 13, 2024
Analysis of the shorter drug survival times for Janus kinase inhibitors and interleukin-17 inhibitors compared with tumor necrosis factor inhibitors in a real-world cohort of axial spondyloarthritis patients - a retrospective analysis from the RHADAR networkPatrick-Pascal Strunz, Matthias Englbrecht, Linus Maximilian Risser, et al.
Frontiers in Public Health|March 11, 2022
Patient's Perception of Digital Symptom Assessment Technologies in Rheumatology: Results From a Multicentre StudyJohannes Knitza, Felix Muehlensiepen, Yuriy Ignatyev, et al.
Journal of Medical Internet Research|July 23, 2024
Diagnostic Accuracy of a Mobile AI-Based Symptom Checker and a Web-Based Self-Referral Tool in Rheumatology: Multicenter Randomized Controlled TrialJohannes Knitza, Koray Tascilar, Franziska Fuchs, et al.
Pageof 5